Table 3.
Mean | SD | Mean | SD | Mean | SD | p value | |
---|---|---|---|---|---|---|---|
Adiponectin (μg/mL) | < 3.1 | <5.4 | <13.2 | ||||
N= | 18 | 20 | 18 | ||||
%Male | 72 | 58 | 28 | 0.024* | |||
Leptin (ng/mL) | <5.4 | <10.6 | <95.2 | ||||
N= | 18 | 19 | 19 | ||||
IL-6 | 2.0 | 0.9 | 2.6 | 1.8 | 3.6 | 2.1 | 0.02‡ |
%Male | 83 | 47 | 28 | 0.003* | |||
BMI | 23.7 | 3.5 | 25.6 | 3.5 | 32.7 | 8.9 | 0.0001‡ |
IL-6 (pg/mL) | <1.7 | <2.7 | <9.0 | ||||
N= | 18 | 20 | 18 | ||||
Leptin | 7.5 | 6.0 | 8 | 5.5 | 20.2 | 20.7 | 0.003‡ |
%Male | 67 | 67 | 26 | 0.017* | |||
BMI | <24.4 | <27.9 | <63.1 | ||||
N= | 20 | 18 | 18 | ||||
Leptin | 6 | 4.4 | 8.3 | 21.9 | 20.4 | 0.0005‡ |
Note: All serum, clinical and microbial parameters were included in the analysis. Due to the high number of variables evaluated, only those that presented differences with associated p values<0.05 were included in the table.
Chi-square analysis
Kruskall-Wallis analysis.